Reuters logo
BRIEF-Karyopharm Q3 loss per share $0.65
2017年11月2日 / 中午12点00分 / 18 天前

BRIEF-Karyopharm Q3 loss per share $0.65

Nov 2 (Reuters) - Karyopharm Therapeutics Inc:

* Karyopharm reports third quarter 2017 financial results and highlights recent progress

* Q3 loss per share $0.65

* Q3 earnings per share view $-0.65 -- Thomson Reuters I/B/E/S

* Karyopharm Therapeutics Inc - ‍expect to report top-line results of phase 2b storm study by april 2018​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below